Longevity Biomarkers: ApoB, HbA1c and the Tests Researchers Watch

Longevity medicine relies heavily on testing. Some tests have decades of research behind them and guide proven treatments. Others, like many "biological age" clocks, are fascinating but not yet ready to guide decisions. Here's a guide to the markers with the strongest evidence.

ApoB: a better measure of cardiovascular risk

Cardiovascular disease remains a leading cause of death. Apolipoprotein B (ApoB) is a protein found on each particle of LDL, VLDL and other atherogenic lipoproteins. Because each particle carries one ApoB molecule, measuring ApoB gives a count of potentially artery-clogging particles.

A 2022 paper in the Journal of the American Heart Association explained the physiological basis for ApoB being superior to LDL cholesterol and non-HDL cholesterol for predicting risk. A 2024 study in the Journal of the American College of Cardiology found that excess ApoB, beyond what LDL cholesterol predicted, was associated with higher cardiovascular risk in both women and men. A 2024 expert consensus in the Journal of Clinical Lipidology discussed ApoB's role in clinical management. European guidelines (ESC/EAS 2019) already recommend ApoB as an alternative risk marker.

Lipoprotein(a)

Lp(a) is a genetically determined lipoprotein linked to heart disease and aortic stenosis. Many guidelines now recommend measuring it at least once in adulthood.

Blood sugar: HbA1c and fasting glucose

HbA1c reflects average blood sugar over about three months and is used to diagnose prediabetes and diabetes. Fasting insulin and related measures can indicate insulin resistance earlier, though they are less standardized. Continuous glucose monitors are increasingly used by healthy people, but how to interpret their readings in non-diabetic people is still being studied.

Blood pressure

High blood pressure is one of the most important modifiable risk factors for heart disease, stroke and dementia. Home monitoring with a validated cuff provides a more accurate picture than occasional clinic readings.

Inflammation: hs-CRP

High-sensitivity C-reactive protein is a marker of low-grade inflammation associated with cardiovascular risk. It can be raised temporarily by infection or hard training, so context matters.

Kidney and liver function

eGFR, urine albumin and liver enzymes help monitor organ health, especially for people taking supplements or medications. Creatine supplementation can raise creatinine and lower estimated kidney function without actual damage, so tell your clinician if you take it.

Functional biomarkers

Some of the strongest predictors of longevity aren't blood tests:

• Cardiorespiratory fitness (VO2max). One of the strongest mortality predictors.
• Grip strength and leg strength. Linked to mortality and independence.
• Body composition, especially visceral fat and muscle mass.
• Gait speed and balance in older adults.

Biological age clocks

Epigenetic clocks estimate "biological age" from DNA methylation patterns. They're valuable research tools and correlate with mortality risk, but results can vary between tests and over short periods, and they aren't validated for guiding individual treatment decisions.

Avoiding over-testing

More tests can lead to false alarms, anxiety and unnecessary follow-up. A good approach is to focus on tests that change decisions and to work with a clinician who can interpret results in context.

Turning numbers into decisions

Biomarkers are only useful if they lead to better decisions. A clinician interpreting results typically considers:

• Your overall risk, combining age, family history, smoking, blood pressure, lipids, blood sugar and other factors, rather than looking at one number in isolation.
• Trends over time. A single result can be affected by a recent illness, hard training, fasting state or lab variation. Repeating a test can clarify a borderline value.
• Which interventions are proven to change the outcome, not just the marker. Lowering ApoB-containing lipoproteins and blood pressure has strong outcome evidence; changing many experimental markers does not yet.
• Lifestyle first, then medication where appropriate. Exercise, diet, sleep and weight management improve many markers, and medications are added when risk remains high.

Direct-to-consumer testing has made large panels easy to order. That can be empowering, but it also produces many borderline or unusual results that can be hard to interpret without context. Bringing results to a clinician who can see the whole picture helps avoid both false reassurance and unnecessary worry. Keeping your own spreadsheet of results over the years is a simple habit that makes trends much easier to spot.

Where this fits in longevity science

Longevity research tries to answer two related questions: how to extend lifespan (how long we live) and how to extend healthspan (how long we live in good health). Much of the field is organized around the "hallmarks of aging," a set of biological processes such as nutrient sensing, mitochondrial function, inflammation and cellular senescence that are thought to drive age-related decline.

The interventions with the strongest human evidence for healthy aging are still behavioral: regular aerobic and strength training, not smoking, healthy body composition, good sleep, a diet built on whole foods, and managing blood pressure, lipids and blood sugar. Drugs and supplements studied for aging, from rapamycin to NAD+ precursors, are being tested against that backdrop. For most of them, the human data are early.

A useful rule of thumb is that anything that sounds like it adds decades to life is almost certainly overstated, while the boring basics quietly have the best data. We try to give you both the exciting science and that honest perspective.

Key terms

• Lifespan: how long an organism lives.
• Healthspan: the years lived in good health, free of serious disease or disability.
• Hallmarks of aging: biological processes believed to drive aging.
• mTOR: a nutrient-sensing pathway that regulates cell growth.
• Autophagy: the process cells use to break down and recycle damaged components.
• Observational study: research that follows people without assigning an intervention; it can show associations but not prove causation.
• Confounding: when a third factor explains an apparent link between two things.
• Meta-analysis: a statistical combination of results from multiple studies.

The bottom line

ApoB, Lp(a), blood pressure, HbA1c and fitness measures are among the best-supported markers for long-term health. Biological age clocks are promising but experimental. Talk to a clinician about which tests are right for you.

How to evaluate a new claim on this topic

New studies, podcasts and social posts appear every week. Before acting on any of them, run the claim through a quick checklist:

1. Find the original study. Search the title or author on PubMed. If a claim can't be traced to a published paper, treat it as opinion.
2. Check the species. Cell, worm and mouse studies generate ideas; human trials test them. Many promising animal findings never replicate in people.
3. Look for a control group. Without a placebo or comparison group, it is impossible to separate the effect of the intervention from time, expectation or other changes.
4. Note the size and length. Small, short studies are useful signals but frequently overturned by larger, longer ones.
5. Look at the outcome. A change in a lab marker is not the same as feeling better, performing better or living longer.
6. Ask who funded it. Industry funding doesn't make a study wrong, but it is a reason to look for independent replication.
7. Read the side-effect section. "No serious adverse events" in 30 people over 8 weeks says little about long-term safety.
8. Ask what it would replace. The best-proven basics, such as sleep, strength training, aerobic fitness and diet quality, usually deliver more than any single add-on.

If a claim survives that checklist, it is worth discussing with a qualified clinician who knows your history.

Frequently asked questions

Is ApoB better than LDL cholesterol?

Research suggests ApoB more accurately reflects atherogenic particle number and risk, especially when the two disagree.

Should everyone test Lp(a)?

Many guidelines recommend testing at least once in adulthood.

Are biological age tests accurate?

They're useful research tools but not yet validated for individual decisions.

What's the most important longevity biomarker?

There isn't one. Fitness, blood pressure and ApoB are among the strongest.

Should healthy people use continuous glucose monitors?

Interpretation in non-diabetic people is still being studied.

Sources

• 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J, 2020. PubMed 31504418
• Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association. J Clin Lipidol, 2024. PubMed 39256087
• Excess Apolipoprotein B and Cardiovascular Risk in Women and Men. J Am Coll Cardiol, 2024. PubMed 38839200
• Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk. J Am Heart Assoc, 2022. PubMed 36216435

Medical disclaimer

This article is for general educational purposes only and is not medical advice. It does not provide dosing instructions and should not be used to diagnose, treat or prevent any condition. Many compounds discussed on this site are not approved for human use, and some are prohibited in tested sport. Always talk to a licensed physician or other qualified health professional before starting, stopping or changing any medication, supplement, diet or training program. Morpheus Research Learn is an educational hub: nothing on these pages is an offer to sell any peptide, drug or supplement, and nothing here is a recommendation to use one.

Sourcing for your lab? See Morpheus Research's third-party tested research peptides.